SUTTON, Lesley-Ann, Emma YOUNG, Panagiotis BALIAKAS, Anastasia HADZIDIMITRIOU, Theodoros MOYSIADIS, Karla PLEVOVÁ, Davide ROSSI, Jana KMÍNKOVÁ, Evangelia STALIKA, Lone Bredo PEDERSEN, Jitka MALČÍKOVÁ, Andreas AGATHANGELIDIS, Zadie DAVIS, Larry MANSOURI, Lydia SCARFO, Myriam BOUDJOGHRA, Alba NAVARRO, Alice F. MUGGEN, Xiao-Jie YAN, Florence NGUYEN-KHAC, Marta LARRAYOZ, Panagiotis PANAGIOTIDIS, Nicholas CHIORAZZI, Carsten Utoft NIEMANN, Chrysoula BELESSI, Elias CAMPO, Jonathan C. STREFFORD, Anton W. LANGERAK, David OSCIER, Gianluca GAIDANO, Šárka POSPÍŠILOVÁ, Frederic DAVI, Paolo GHIA, Kostas STAMATOPOULOS and Richard ROSENQUIST. Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors. Haematologica. PAVIA: FERRATA STORTI FOUNDATION, 2016, vol. 101, No 8, p. 959-967. ISSN 0390-6078. Available from: https://dx.doi.org/10.3324/haematol.2016.141812.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors
Authors SUTTON, Lesley-Ann (752 Sweden), Emma YOUNG (840 United States of America), Panagiotis BALIAKAS (752 Sweden), Anastasia HADZIDIMITRIOU (300 Greece), Theodoros MOYSIADIS (300 Greece), Karla PLEVOVÁ (203 Czech Republic, belonging to the institution), Davide ROSSI (380 Italy), Jana KMÍNKOVÁ (203 Czech Republic, belonging to the institution), Evangelia STALIKA (300 Greece), Lone Bredo PEDERSEN (208 Denmark), Jitka MALČÍKOVÁ (203 Czech Republic, belonging to the institution), Andreas AGATHANGELIDIS (380 Italy), Zadie DAVIS (826 United Kingdom of Great Britain and Northern Ireland), Larry MANSOURI (752 Sweden), Lydia SCARFO (380 Italy), Myriam BOUDJOGHRA (250 France), Alba NAVARRO (724 Spain), Alice F. MUGGEN (528 Netherlands), Xiao-Jie YAN (840 United States of America), Florence NGUYEN-KHAC (250 France), Marta LARRAYOZ (826 United Kingdom of Great Britain and Northern Ireland), Panagiotis PANAGIOTIDIS (300 Greece), Nicholas CHIORAZZI (840 United States of America), Carsten Utoft NIEMANN (208 Denmark), Chrysoula BELESSI (300 Greece), Elias CAMPO (724 Spain), Jonathan C. STREFFORD (826 United Kingdom of Great Britain and Northern Ireland), Anton W. LANGERAK (528 Netherlands), David OSCIER (826 United Kingdom of Great Britain and Northern Ireland), Gianluca GAIDANO (380 Italy), Šárka POSPÍŠILOVÁ (203 Czech Republic, guarantor, belonging to the institution), Frederic DAVI (250 France), Paolo GHIA (380 Italy), Kostas STAMATOPOULOS (300 Greece) and Richard ROSENQUIST (752 Sweden).
Edition Haematologica, PAVIA, FERRATA STORTI FOUNDATION, 2016, 0390-6078.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher Italy
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 7.702
RIV identification code RIV/00216224:14740/16:00090992
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.3324/haematol.2016.141812
UT WoS 000381941900019
Keywords in English ANTIGEN RECEPTORS; GENOMIC ABERRATIONS; EXPRESSION PROFILES; SF3B1; SELECTION; TP53; CLL; SUBGROUPS; INDICATE; PATTERNS
Tags MEDGENET, rivok
Changed by Changed by: Mgr. Eva Špillingová, učo 110713. Changed: 6/12/2016 13:27.
Abstract
We report on markedly different frequencies of genetic lesions within subsets of chronic lymphocytic leukemia patients carrying mutated or unmutated stereotyped B-cell receptor immunoglobulins in the largest cohort (n=565) studied for this purpose. By combining data on recurrent gene mutations (BIRC3, MYD88, NOTCH1, SF3B1 and TP53) and cytogenetic aberrations, we reveal a subset-biased acquisition of gene mutations. More specifically, the frequency of NOTCH1 mutations was found to be enriched in subsets expressing unmutated immunoglobulin genes, i.e. #1, #6, #8 and #59 (22-34%), often in association with trisomy 12, and was significantly different (P<0.001) to the frequency observed in subset #2 (4%, aggressive disease, variable somatic hypermutation status) and subset #4 (1%, indolent disease, mutated immunoglobulin genes). Interestingly, subsets harboring a high frequency of NOTCH1 mutations were found to carry few (if any) SF3B1 mutations. This starkly contrasts with subsets #2 and #3 where, despite their immunogenetic differences, SF3B1 mutations occurred in 45% and 46% of cases, respectively. In addition, mutations within TP53, whilst enriched in subset #1 (16%), were rare in subsets# 2 and #8 (both 2%), despite all being clinically aggressive. All subsets were negative for MYD88 mutations, whereas BIRC3 mutations were infrequent. Collectively, this striking bias and skewed distribution of mutations and cytogenetic aberrations within specific chronic lymphocytic leukemia subsets implies that the mechanisms underlying clinical aggressiveness are not uniform, but rather support the existence of distinct genetic pathways of clonal evolution governed by a particular stereotyped B-cell receptor selecting a certain molecular lesion(s).
Links
ED1.1.00/02.0068, research and development projectName: CEITEC - central european institute of technology
PrintDisplayed: 1/8/2024 16:17